Figure 1 shows an example of a nanopublication which attempts to express the assertion from Spilman et al.[27] that “inhibition of mTOR by rapamycin can slow or block AD progression in a transgenic mouse model of the disease”. This evidence concerns the gene MTOR and Alzheimer disease.